Elvitegravir
Showing 1 - 25 of 101
HIV Trial in Birmingham, Pittsburgh (TAF/EVG Insert)
Completed
- HIV Infections
- TAF/EVG Insert
-
Birmingham, Alabama
- +1 more
Apr 20, 2022
HIV-1-infection Trial in Saint Louis (Biktarvy Tab)
Terminated
- HIV-1-infection
- Biktarvy Tab
-
Saint Louis, MissouriSouthampton Healthcare, Inc.
Jan 3, 2023
Healthy Volunteers Trial in Baltimore (Genvoya Oral dose, Genvoya Crushed Dose)
Completed
- Healthy Volunteers
- Genvoya Oral dose
- Genvoya Crushed Dose
-
Baltimore, MarylandJohns Hopkins University
Nov 9, 2021
Safety Issues Trial in Norfolk, Thika, Durban (TAF/EVG vaginal insert, Matching Placebo vaginal insert)
Not yet recruiting
- Safety Issues
- TAF/EVG vaginal insert
- Matching Placebo vaginal insert
-
Norfolk, Virginia
- +2 more
Oct 11, 2023
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
HIV, Severe Immunosuppression Trial in Marbella, Madrid, Sevilla (Genvoya®)
Completed
- HIV Infections
- Severe Immunosuppression
-
Marbella, Malaga, Spain
- +5 more
Aug 6, 2020
HIV/AIDS Trial (Elvitegravir, Cobicistat, TAF, FTC, Efavirenz, TDF, and 3TC)
Withdrawn
- HIV/AIDS
- Elvitegravir, Cobicistat, TAF, FTC
- Efavirenz, TDF, and 3TC
- (no location specified)
Mar 16, 2020
Neurologic and Psychiatric Adverse Events of Several
Terminated
- HIV
- prescription of at least one of the following drugs: rilpivirine, elvitegravir, dolutegravir
-
Paris, FranceFrance
Feb 25, 2020
HIV Trial in San Diego (Stribild, Genvoya)
Completed
- HIV
-
San Diego, CaliforniaUC San Diego AntiViral Research Center
Oct 8, 2019
HIV Trial in Majadahonda, Madrid (ELV/COBI/FTC/TAF, DTG/3TC/ABC + ELV/COBI/FTC/TAF)
Completed
- HIV Infections
- ELV/COBI/FTC/TAF
- DTG/3TC/ABC + ELV/COBI/FTC/TAF
-
Majadahonda, Madrid, Spain
- +5 more
Feb 3, 2020
HIV-1 Infection Trial in Worldwide (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or
Active, not recruiting
- HIV-1 Infection
- elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
-
Birmingham, Alabama
- +29 more
Jan 24, 2022
HIV-1-infection, Hepatitis C, Chronic, Methadone Dependence Trial in Regina (Genvoya, Epclusa, Biktarvy)
Unknown status
- HIV-1-infection
- +8 more
- Genvoya
- +2 more
-
Regina, Saskatchewan, CanadaSaskatchewan Health Authority
Dec 23, 2019
Chronic Hepatitis B in HIV Patient, Kidney Injury, Bone Diseases Trial in Taipei (Elvitegravir/Cobicistat/Emtricitabine)
Unknown status
- Chronic Hepatitis B in HIV Patient
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 25, 2019
Bictegravir in the Elderly Living With HIV (BICEP)
Active, not recruiting
- HIV-1-infection
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Buffalo, New YorkEvergreen Health
Oct 28, 2022
HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)
Recruiting
- HIV I Infection
- +2 more
- Doravirine 100 Mg
-
Los Angeles, California
- +1 more
Nov 1, 2022
HIV Trial in Nijmegen (Stribild, Stribild, crushed)
Completed
- HIV
- Stribild
- Stribild, crushed
-
Nijmegen, NetherlandsCRCN, Radboud University Medical Center
Mar 11, 2021
Hiv, HSV Trial in Norfolk (TAF/EVG Vaginal Insert)
Completed
- Hiv
- HSV
- TAF/EVG Vaginal Insert
-
Norfolk, VirginiaClinical Research Center at Eastern Virginia Medical School (NOT
Jul 15, 2019
Antiretroviral Drugs and Related Drugs During and After
Antiretroviral Agents in HIV-infected Pregnant Women.
Recruiting
- HIV Infections
-
Brussels, Belgium
- +20 more
Nov 28, 2022